Nicole Bürki

Summary

Affiliation: Kantonsspital Liestal
Country: Switzerland

Publications

  1. doi [Hereditary breast and ovarian cancer - indications for genetic testing, counseling and options for mutation carriers]
    Nicole Bürki
    Frauenklinik, Kantonsspital Liestal
    Ther Umsch 67:359-66. 2010
  2. pmc Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors
    Corina Kohler
    Laboratory for Prenatal Medicine and Gynecologic Oncology, Women s Hospital Department of Biomedicine, University of Basel, Switzerland
    Mol Cancer 8:105. 2009
  3. doi Evidence for breast cancer as an integral part of Lynch syndrome
    Nicole Buerki
    Department of Obstetrics and Gynecology, Cantonal Hospital of Liestal, Liestal, Switzerland
    Genes Chromosomes Cancer 51:83-91. 2012

Collaborators

  • Ramin Radpour
  • Nicole Buerki
  • Corina Kohler
  • Michal Kovac
  • Lucienne Gautier
  • Mauro Buser
  • Hansjakob Mueller
  • Karl Heinimann
  • Giancarlo Marra
  • Zeinab Barekati
  • Xiao Yan Zhong
  • Wolfgang Holzgreve
  • Johannes Bitzer
  • Claude Diesch
  • Reza Asadollahi
  • Edward Wight

Detail Information

Publications3

  1. doi [Hereditary breast and ovarian cancer - indications for genetic testing, counseling and options for mutation carriers]
    Nicole Bürki
    Frauenklinik, Kantonsspital Liestal
    Ther Umsch 67:359-66. 2010
    ..Each of the three management options 'intensified cancer screening', 'chemoprevention' and 'prophylactic surgery' is discussed thoroughly. Recommended cancer screening in male mutation carriers are mentioned as well...
  2. pmc Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors
    Corina Kohler
    Laboratory for Prenatal Medicine and Gynecologic Oncology, Women s Hospital Department of Biomedicine, University of Basel, Switzerland
    Mol Cancer 8:105. 2009
    ..In this connection, circulating cell-free DNA (ccf DNA) seems to be a promising candidate. Altered levels of ccf nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) have been found in several cancer types and might have a diagnostic value...
  3. doi Evidence for breast cancer as an integral part of Lynch syndrome
    Nicole Buerki
    Department of Obstetrics and Gynecology, Cantonal Hospital of Liestal, Liestal, Switzerland
    Genes Chromosomes Cancer 51:83-91. 2012
    ..7%) of 22 breast cancer specimens from MLH1/MSH2 mutation carriers. These findings, thus, provide strong molecular evidence for a pivotal role of MMR deficiency in breast cancer development in Lynch syndrome...